🇺🇸 Brimonidine tartrate ophthalmic solution 0.025% in United States

Brimonidine tartrate ophthalmic solution 0.025% (Brimonidine tartrate ophthalmic solution 0.025%) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Brimonidine tartrate ophthalmic solution 0.025% in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Brimonidine tartrate ophthalmic solution 0.025% approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Brimonidine tartrate ophthalmic solution 0.025% in United States?

Bausch & Lomb Incorporated is the originator. The local marketing authorisation holder may differ — check the official source linked above.